These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24583245)

  • 21. The role of GIP and pancreatic GLP-1 in the glucoregulatory effect of DPP-4 inhibition in mice.
    Hutch CR; Roelofs K; Haller A; Sorrell J; Leix K; D'Alessio DD; Augustin R; Seeley RJ; Klein T; Sandoval DA
    Diabetologia; 2019 Oct; 62(10):1928-1937. PubMed ID: 31414143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A DPP-IV-resistant triple-acting agonist of GIP, GLP-1 and glucagon receptors with potent glucose-lowering and insulinotropic actions in high-fat-fed mice.
    Bhat VK; Kerr BD; Vasu S; Flatt PR; Gault VA
    Diabetologia; 2013 Jun; 56(6):1417-24. PubMed ID: 23503814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Important species differences regarding lymph contribution to gut hormone responses.
    Hansen M; Hjøllund KR; Hartmann B; Plamboeck A; Deacon CF; Wewer Albrechtsen NJ; Holst JJ
    Peptides; 2015 Sep; 71():28-31. PubMed ID: 26048091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ezetimibe stimulates intestinal glucagon-like peptide 1 secretion via the MEK/ERK pathway rather than dipeptidyl peptidase 4 inhibition.
    Chang E; Kim L; Choi JM; Park SE; Rhee EJ; Lee WY; Oh KW; Park SW; Park DI; Park CY
    Metabolism; 2015 May; 64(5):633-41. PubMed ID: 25704082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of dipeptidyl peptidase-4 by vildagliptin during glucagon-like Peptide 1 infusion increases liver glucose uptake in the conscious dog.
    Edgerton DS; Johnson KM; Neal DW; Scott M; Hobbs CH; Zhang X; Duttaroy A; Cherrington AD
    Diabetes; 2009 Jan; 58(1):243-9. PubMed ID: 18840785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nutrient-driven incretin secretion into intestinal lymph is different between diabetic Goto-Kakizaki rats and Wistar rats.
    Kindel TL; Yang Q; Yoder SM; Tso P
    Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G168-74. PubMed ID: 19056762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice.
    Ahrén B; Holst JJ; Mårtensson H; Balkan B
    Eur J Pharmacol; 2000 Sep; 404(1-2):239-45. PubMed ID: 10980284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue expression of DPP-IV in obesity-diabetes and modulatory effects on peptide regulation of insulin secretion.
    McKillop AM; Stevenson CL; Moran BM; Abdel-Wahab YHA; Flatt PR
    Peptides; 2018 Feb; 100():165-172. PubMed ID: 29412816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergism by individual macronutrients explains the marked early GLP-1 and islet hormone responses to mixed meal challenge in mice.
    Ahlkvist L; Vikman J; Pacini G; Ahrén B
    Regul Pept; 2012 Oct; 178(1-3):29-35. PubMed ID: 22750278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide stimulate release of substance P from TRPV1- and TRPA1-expressing sensory nerves.
    Mayer F; Gunawan AL; Tso P; Aponte GW
    Am J Physiol Gastrointest Liver Physiol; 2020 Jul; 319(1):G23-G35. PubMed ID: 32421358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig.
    Deacon CF; Hughes TE; Holst JJ
    Diabetes; 1998 May; 47(5):764-9. PubMed ID: 9588448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased GLP-1 response after gavage-administration of glucose in UCP2-deficient mice.
    Zhang H; Li J; Li Z; Luo Y
    Horm Metab Res; 2012 Feb; 44(2):86-90. PubMed ID: 22198816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obese Zucker rats.
    Balkan B; Kwasnik L; Miserendino R; Holst JJ; Li X
    Diabetologia; 1999 Nov; 42(11):1324-31. PubMed ID: 10550416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incretin and islet hormonal responses to fat and protein ingestion in healthy men.
    Carr RD; Larsen MO; Winzell MS; Jelic K; Lindgren O; Deacon CF; Ahrén B
    Am J Physiol Endocrinol Metab; 2008 Oct; 295(4):E779-84. PubMed ID: 18612044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between anagliptin concentration showing over 80% inhibition of plasma dipeptidyl peptidase-4 activity and its protective effect against glucagon-like peptide-1 degradation.
    Furuta S; Goto M; Tamura M; Yamashita S; Nakaya K; Furuta Y
    Drug Res (Stuttg); 2014 Mar; 64(3):130-5. PubMed ID: 23965798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion.
    Lugari R; Dei Cas A; Ugolotti D; Barilli AL; Camellini C; Ganzerla GC; Luciani A; Salerni B; Mittenperger F; Nodari S; Gnudi A; Zandomeneghi R
    Horm Metab Res; 2004 Feb; 36(2):111-5. PubMed ID: 15002062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel glucagon-like peptide-1 (GLP-1)/glucagon hybrid peptide with triple-acting agonist activity at glucose-dependent insulinotropic polypeptide, GLP-1, and glucagon receptors and therapeutic potential in high fat-fed mice.
    Gault VA; Bhat VK; Irwin N; Flatt PR
    J Biol Chem; 2013 Dec; 288(49):35581-91. PubMed ID: 24165127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutral endopeptidase 24.11 and dipeptidyl peptidase IV are both mediators of the degradation of glucagon-like peptide 1 in the anaesthetised pig.
    Plamboeck A; Holst JJ; Carr RD; Deacon CF
    Diabetologia; 2005 Sep; 48(9):1882-90. PubMed ID: 16025254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High DPP-4 Concentrations in Adolescents Are Associated With Low Intact GLP-1.
    Stenlid R; Manell H; Halldin M; Kullberg J; Ahlström H; Manukyan L; Weghuber D; Paulmichl K; Zsoldos F; Bergsten P; Forslund A
    J Clin Endocrinol Metab; 2018 Aug; 103(8):2958-2966. PubMed ID: 29850829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of intestinal dipeptidyl peptidase-4 inhibition for incretin-dependent improved glucose tolerance in mice.
    Yamashita S; Kawakami Y; Sato H; Sugitani S; Goto M; Kato N
    Eur J Pharmacol; 2019 Sep; 859():172521. PubMed ID: 31276666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.